GlassScriptPhysician profile
Joseph P Sullivan
NPI 1225262561
$6,167.48
in general payments reported to CMS, 2019-2025
24 companies · $623 in 2025
The $623 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $712 · 2021: $515 · 2022: $946 · 2023: $2,330 · 2024: $598 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,859 · Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,859.33 |
| Food and Beverage | $1,691.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,397.45 | 2019-2024 | Omnia, Senza |
| Abbvie INC. | $830.10 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Globus Medical, INC. | $486.62 | 2025 | Senza |
| Si-Bone, INC. | $356.35 | 2019-2024 | |
| Bioness INC | $238.14 | 2020 | |
| Amgen INC. | $195.54 | 2019-2021 | |
| Lilly USA, LLC | $77.79 | 2020-2023 | Reyvow, Emgality |
| Boston Scientific Corporation | $75.18 | 2021-2022 | |
| Stryker Corporation | $69.73 | 2022-2023 | Spinejack |
| Pacira Therapeutics, INC. | $56.20 | 2019-2020 | |
| Pfizer INC. | $51.75 | 2020-2025 | |
| Collegium Pharmaceutical, INC. | $41.59 | 2020 | |
| Medtronic, INC. | $40.51 | 2022-2025 | Inceptiv |
| Novartis Pharmaceuticals Corporation | $33.57 | 2019 | |
| Allergan, INC. | $30.06 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $27.52 | 2020 | |
| Assertio Therapeutics, INC. | $27.42 | 2019 | |
| Upsher-Smith Laboratories LLC | $26.05 | 2020 | |
| Radius Health, INC. | $24.23 | 2019 | |
| Biodelivery Sciences International, INC. | $19.15 | 2019 | |
| Horizon Therapeutics Plc | $17.74 | 2022 | |
| Merz Pharmaceuticals, LLC | $15.85 | 2025 | Xeomin |
| Medtronic USA, INC. | $14.60 | 2020 | |
| Depuy Synthes Sales INC. | $14.34 | 2023 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.